Scholarly Index
Xin Lu
Sanofi (United States); 1,446 total citations; 65 total publications; best world rank #25
Sanofi (United States)
1,446Total citations
65Total publications
21H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 500 | US 164 | 93.86 |
| Skin Diseases and Diabetes | Lifetime | 605 | US 207 | 85.85 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 56 | US 22 | 96.75 |
| Skin Diseases and Diabetes | 2021-2025 | 25 | US 12 | 90.14 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 146 | US 72 | 93.68 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 523 | US 142 | 88.74 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 154 | US 46 | 71.43 |